In April 2025, ENZOEYS obtained its Class II Medical Device Manufacturing License, establishing itself as a nationally certified manufacturer of high-end medical aesthetics equipment. This stringently reviewed qualification validates the company's robust technological and quality capabilities. Founded in 1986, ENZOEYS holds over 100 patents with products exported globally. Following license approval, ENZOEYS upgraded its full product lifecycle management system. Looking ahead, ENZOEYS will launch five new products as part of its transformation strategy, setting a benchmark for industry development.

Dubai Derma 2025 took place from April 14-16 at the Dubai World Trade Centre, attracting over 700 brands and more than 25,000 professional attendees. Our two flagship brands, ENZOEYS and CIELLULU, participated in the exhibition, showcasing the super photorejuvenation product series. The event resulted in preliminary partnership agreements with agents from over 30 countries. Looking forward, ENZOEYS will deepen global collaboration to jointly expand the aesthetic medicine market.

The 13th Chinese Conference of Laser Cosmetic Therapy and Facial Rejuvenation (CCLR) was held in Shanghai from April 17-20, 2025. ENZOEYS unveiled its innovative products at the event, highlighting semiconductor-based dual-effect skin rejuvenation solutions featuring three core technological breakthroughs. Its flagship products, including Mura K2 and SuperTouch S500, attracted significant attention. The solution aligns with life cosmetology and medical cosmetology evolution. Our exhibitors also discussed with experts on industry topics, proving the corporate philosophy of Technology Drives Beauty Industry Evolution.

In February 2025, ENZOEYS and Japan Zeus Corporation signed a strategic cooperation agreement in Guangzhou, with a South Korean company participating as technical co-organizer. Senior executives from both parties attended the ceremony. This partnership marks the successful passage of the ENZOEYS brand RUIKD through Japanese stringent market certification, paving the way for in-depth collaboration in technological innovation and […]

Dubai Derma 2025 took place from April 14-16 at the Dubai World Trade Centre. At its strategic booth 3F103, ENZOEYS showcased its disruptive photoelectric technology innovation and made its debut of the complete FDA-approved MULA Series Device Portfolio to the Asia-Pacific market. Among the featured products, the MULA K2-A1 Gold Super-Photon is drawing strong interest from major Southeast Asian clinics for on-site testing.